Alvotech And Cipla Strike Biosimilars Alliance In South Africa

Deal Covers Five Undisclosed Biosimilars

 
• By Dean Rudge
running athletic race track with blending South Africa flag
The partnership provides for five biosimilars – two for oncology and three for treating autoimmune diseases – in certain emerging markets, including South Africa. • Source: Shutterstock

More from Biosimilars

More from Products